These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 23236978)

  • 1. OCT-verified neoatherosclerosis in BMS restenosis at 10 years.
    Kang SJ; Song HG; Ahn JM; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
    JACC Cardiovasc Imaging; 2012 Dec; 5(12):1267-8. PubMed ID: 23236978
    [No Abstract]   [Full Text] [Related]  

  • 2. Coronary angioscopy and optical coherence tomography for confirmation of drug-coated neointimal plaque after paclitaxel-coated balloon angioplasty for in-stent restenosis.
    Yoneyama K; Koyama K; Tanabe Y; Mitarai T; Kamijima R; Kuwata S; Yamazaki H; Nakano E; Kongoji K; Harada T; Akashi YJ
    Int J Cardiol; 2014 Oct; 176(3):1207-9. PubMed ID: 25129263
    [No Abstract]   [Full Text] [Related]  

  • 3. Atypical "vacuum" inside of neoatherosclerosis long term after DES implantation: insights from optical coherence tomography.
    Granata F; Attizzani GF; Tartaglione D; Cappelli Bigazzi M; Bianchi R; Varricchio A; Russo MG; Calabrò P
    Int J Cardiol; 2015 Nov; 199():221-2. PubMed ID: 26209822
    [No Abstract]   [Full Text] [Related]  

  • 4. Optical coherence tomography visualization of a ruptured plaque after bare-metal stent implantation.
    Kim S; Ko YG; Shin DH; Kim JS; Kim BK; Choi D; Hong MK; Jang Y
    Can J Cardiol; 2012; 28(4):516.e11-2. PubMed ID: 22326713
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation between degree of neointimal hyperplasia and incidence and characteristics of neoatherosclerosis as assessed by optical coherence tomography.
    Vergallo R; Yonetsu T; Uemura S; Park SJ; Lee S; Kato K; Jia H; Abtahian F; Tian J; Hu S; Lee H; McNulty I; Prasad A; Yu B; Zhang S; Porto I; Biasucci LM; Crea F; Jang IK
    Am J Cardiol; 2013 Nov; 112(9):1315-21. PubMed ID: 23891431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical coherence tomography-based predictors for creatine kinase-myocardial band elevation after elective percutaneous coronary intervention for in-stent restenosis.
    Lee SY; Hong MK; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y
    Catheter Cardiovasc Interv; 2015 Mar; 85(4):564-72. PubMed ID: 25158217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravascular optical coherence tomographic (OCT) findings late after intracoronary beta brachytherapy.
    Doustaly R; Siegwald J; Naoum C; Yong AS; Savvides M; Lowe HC
    Int J Cardiol; 2013 Oct; 168(3):e87-8. PubMed ID: 23928343
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of Strut Coverage at 6 Months by Optical Coherence Tomography With Everolimus-Eluting Stenting of Bare-Metal Stent Restenosis Versus Stenosis of Nonstented Atherosclerotic Narrowing (from the DESERT Study).
    Picchi A; Musumeci G; Calabria P; Cresti A; Rescigno R; Aruffo A; Prati F; Limbruno U
    Am J Cardiol; 2015 May; 115(10):1351-6. PubMed ID: 25772742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography.
    Kim S; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Cho YK; Nam CW; Hur SH; Jang Y; Hong MK
    Am J Cardiol; 2013 Jan; 111(1):1-5. PubMed ID: 23040589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Optical Coherence Tomography in the Assessment of Stent Deformation.
    Abdel-Hadi H; Shah AH; Džavík V
    Can J Cardiol; 2016 Mar; 32(3):396.e1-2. PubMed ID: 26921163
    [No Abstract]   [Full Text] [Related]  

  • 11. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation.
    Lee SY; Hur SH; Lee SG; Kim SW; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001878. PubMed ID: 25613674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical coherence tomography-based evaluation of in-stent neoatherosclerosis in lesions with more than 50% neointimal cross-sectional area stenosis.
    Lee SY; Shin DH; Mintz GS; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    EuroIntervention; 2013 Dec; 9(8):945-51. PubMed ID: 24384291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue coverage and neointimal hyperplasia in overlap versus nonoverlap segments of drug-eluting stents 9 to 13 months after implantation: in vivo assessment with optical coherence tomography.
    Gutiérrez-Chico JL; Räber L; Regar E; Okamura T; di Mario C; van Es GA; Windecker S; Serruys PW
    Am Heart J; 2013 Jul; 166(1):83-94. PubMed ID: 23816026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal visualization of five different stent layers during and after percutaneous coronary intervention for recurrent in-stent restenosis using optical coherence tomography (OCT).
    Movahed MR; Ram V; Arsanjani R
    Cardiovasc Revasc Med; 2012; 13(5):292-4. PubMed ID: 22727600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appearance of neointima according to stent type and restenotic phase: analysis by optical coherence tomography.
    Goto K; Takebayashi H; Kihara Y; Hagikura A; Fujiwara Y; Kikuta Y; Sato K; Kodama S; Taniguchi M; Hiramatsu S; Haruta S
    EuroIntervention; 2013 Sep; 9(5):601-7. PubMed ID: 23518860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial heterogeneity of neoatherosclerosis and its relationship with neovascularization and adjacent plaque characteristics: optical coherence tomography study.
    Tian J; Ren X; Uemura S; Dauerman H; Prasad A; Toma C; Jia H; Abtahian F; Vergallo R; Hu S; McNulty I; Lee H; Lee S; Yu B; Jang IK
    Am Heart J; 2014 Jun; 167(6):884-92.e2. PubMed ID: 24890539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study.
    Davlouros PA; Nikokiris G; Karantalis V; Mavronasiou E; Xanthopoulou I; Damelou A; Tsigkas G; Alexopoulos D
    Int J Cardiol; 2011 Sep; 151(2):155-9. PubMed ID: 20605242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study.
    Taniwaki M; Windecker S; Zaugg S; Stefanini GG; Baumgartner S; Zanchin T; Wenaweser P; Meier B; Jüni P; Räber L
    Eur Heart J; 2015 Aug; 36(32):2167-76. PubMed ID: 26040806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fully bioresorption of an Absorb bioresorbable vascular scaffold after scaffold restenosis.
    Goncalves-Ramírez LR; Gutiérrez H; Rojas P; Cortés C; Serrador A; Ramos B; Toro J; Amat-Santos IJ; San Román JA
    Cardiol J; 2019; 26(2):209-211. PubMed ID: 31032876
    [No Abstract]   [Full Text] [Related]  

  • 20. Intimal hyperplasia by optical coherence tomography after BMS and DES implantation in the same artery.
    Karantalis V; Davlouros P; Alexopoulos D
    Int J Cardiol; 2011 May; 148(3):e66-7. PubMed ID: 19329194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.